Introduction Section

Thank you for your interest in our upcoming nationwide study with PRC. We are looking for Adults 21-39 to participate in the Cannabis study.

Topic: Cannabis 
Who: Adults 21-39
When: September 26, 27, 28, 2023
Length/ Pay: 90minute group, product test, 15 minute follow-up interview/ $200
Where: West Hollywood
As with all PRC studies, participants are booked on a first come first serve basis. Not all participants who complete this pre-questionnaire will qualify for this study, nor will everyone receive a callback. Please do not call in reference to this study. If you pre-qualify, a recruiter will contact you with further questions and details.

By clicking below, you are confirming you understand the above statements and policies. You are also agreeing to fill out this survey honestly to the best of your knowledge.

***Proof may be required to participate in this study***

●      Phase I (90 Min. In-Person FGs):

○      $50 incentive paid at the end of this phase.

○      Must be willing to take 1 deep hit of at least 4 different infused (Pre-Roll) Blunt products in the 90-minute session.

○      Must show proof of age with valid government issued ID

○      Live within 45 minute drive of West Hollywood

○      Has or will download and use the Uber app. We will pay for Ubers to/from home to focus group location

●      Phase II (2 Day in home product testing):

○      They will have up to 7 days to complete this.

○      Must be willing to try 2 different infused (Pre-Roll) Blunts, 1 per day completed in one single sitting.

○      Must provide feedback via mobile optimized survey during each product experience.

■      Estimate 30 mins per day for 2 days out of the 7 days.

○      Required to discard all remaining or unused materials and packaging as instructed.

●      Phase III (15 Min. Virtual zoom interview):

○      $150 incentive paid out once phase III is completed.

○      We will schedule these via Calendly.

○      Must provide feedback on tested products via 15 min recorded Zoom call.